Abstract
Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuous process involving different neurobiological pathways, depending on the stage of addiction. A specific emphasis will be made on the development of dysfunctional automatic behaviors in the late stage of addiction and the central role of glutamate and AMPA receptors. The aim is to propose that if too broad an effect of anti-addiction medication is expected (such as anti-craving, anti-relapse and preventive effects), the results might be disappointing. The speculative specific efficacy of topiramate in addiction is described.
Keywords: Topiramate, addictions, treatment, drug abuse, dysfunctional, hedonic, ritualized, amphetamines, morphine, naltrexone, mesolimbic, synaptic, neuroanatomical, vaccines, ethanol, sensitization, kainate
Current Pharmaceutical Design
Title: The Potential Interest of Topiramate in Addictions
Volume: 17 Issue: 14
Author(s): Gabriel Thorens, Joel Billieux, Rita Manghi, Riaz Khan, Yasser Khazaal and Daniele Fabio Zullino
Affiliation:
Keywords: Topiramate, addictions, treatment, drug abuse, dysfunctional, hedonic, ritualized, amphetamines, morphine, naltrexone, mesolimbic, synaptic, neuroanatomical, vaccines, ethanol, sensitization, kainate
Abstract: Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuous process involving different neurobiological pathways, depending on the stage of addiction. A specific emphasis will be made on the development of dysfunctional automatic behaviors in the late stage of addiction and the central role of glutamate and AMPA receptors. The aim is to propose that if too broad an effect of anti-addiction medication is expected (such as anti-craving, anti-relapse and preventive effects), the results might be disappointing. The speculative specific efficacy of topiramate in addiction is described.
Export Options
About this article
Cite this article as:
Thorens Gabriel, Billieux Joel, Manghi Rita, Khan Riaz, Khazaal Yasser and Fabio Zullino Daniele, The Potential Interest of Topiramate in Addictions, Current Pharmaceutical Design 2011; 17 (14) . https://dx.doi.org/10.2174/138161211796150864
DOI https://dx.doi.org/10.2174/138161211796150864 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones
Central Nervous System Agents in Medicinal Chemistry Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease
Central Nervous System Agents in Medicinal Chemistry Pharmacotherapy of bipolar II disorder during and after pregnancy
Current Drug Safety Adenosine Neuromodulation and Traumatic Brain Injury
Current Neuropharmacology Abnormal Head Posture due to Ocular Problems- A Review
Current Pediatric Reviews Dysregulated Pathway Identification of Alzheimer's Disease Based on Internal Correlation Analysis of Genes and Pathways
Combinatorial Chemistry & High Throughput Screening In Vitro Skin Permeation Enhancement of Sumatriptan by Microneedle Application
Current Drug Delivery Focusing on the Interactions between the GABAergic System and Neurosteroids in Neurodevelopmental Disorders
Current Pharmaceutical Design Structure, Pharmacology and Therapeutic Prospects of Family C G-Protein Coupled Receptors
Current Drug Targets <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal Meet Our Associate Editor
Current Psychopharmacology Exercise-Induced Cardiac Troponin Release: Real-Life Clinical Confusion
Current Medicinal Chemistry Subject Index to Volume 11
Current Medicinal Chemistry 3D MI-DRAGON: New Model for the Reconstruction of US FDA Drug- Target Network and Theoretical-Experimental Studies of Inhibitors of Rasagiline Derivatives for AChE
Current Topics in Medicinal Chemistry Lithium, a Therapy for AD: Current Evidence from Clinical Trials of Neurodegenerative Disorders
Current Alzheimer Research Clinical Uses of Low – Dose Ketamine in Patients Undergoing Surgery
Current Drug Targets Approaching Clinical Reality: Markers for Monitoring Systemic Inflammation and Sepsis
Current Molecular Medicine From Biomarkers to Cytokine-like Hormones: Uncovering New Directives for Cognitive Loss and Alzheimer’s Disease
Current Neurovascular Research Induction of Labour for Maternal Request: An Observational Study of Maternal and Fetal Outcomes
Reviews on Recent Clinical Trials Roles of Cannabidiol in the Treatment and Prevention of Alzheimer’s Disease by Multi-target Actions
Mini-Reviews in Medicinal Chemistry